Week beginning 9th December 2024
News, articles and advocacy
Scotland Deadline news reports that the Scottish Government will be making its first funding commitment for ME after a 22 year wait. The budget for 2025-2026 has outlined an "additional £4.5m funding to deliver new specialist support across the country for new services for Long Covid, ME, Chronic Fatigue and other similar conditions”. Spokesperson for #MEAction Scotland Janet Sylvester calls it a landmark day and adds that it's critical that funding "should only be given to services that commit to implementing the NICE guideline recommendations"
Article l
Thread
Ireland HSE Survey Examining Long-term Impact of Acute COVID 19 Disease
"Due to an unequal response to the survey by age, gender, and self-reported Long COVID status, a statistical adjustment was necessary and estimated that 16% of the population sampled ever experienced symptoms of Long COVID."
Press Release |
Report |
Thread
UK ME Association AGM statement
In response to issues raised at the AGM, the MEA has published a statement under the headings:
1. Investment into research, information, and support programmes
2. Improving operations, introducing new and updated approaches, Governance Review, Transparency, Consultation and Development over the next 18 months
Statement |
Thread
Trial by Error by David Tuller Agencies Respond to Coroner's Report in Boothby O
'Neill's Inquest
An overview of response to the Coroner's Report. Tuller comments: "While any progress in addressing the enormous challenges revealed through the inquest is welcome, how much these steps will advance that goal is another question."
Article l
Thread
Sky News had a 20 minutes segment on ME/CFS and the lack of progress since the coroner Maeve Boothby O´Neill's inquest issued a prevention of future deaths report highlighting the lack of treatments for severe sufferers. The segment has an interview with Heather Gordon, mother of Karen who suffers from severe ME and has been 1 year in hospital without getting a care plan in place for essential nutritional needs. Also talks with Anna Gregorowski from BACME, and with Chris Ponting who says:
"..There needs to be a societal shift. We are turning our backs on more than a quarter of a milion people across the UK, in clinical practice, in schools, in all across different walks of life. We are turning our back as a society on people who need us now, who have needed us for decades.".
News segment l
Thread
Salon Why conditions like chronic fatigue syndrome and long COVID are still so mysterious
"A disease that's prevalent in women highlights the female sex bias in medicine". Contains interview with Chris Ponting from the DecodeME study who says policymakers often are unaware of the devastation of ME and that it flies under the radar. Dr. Charles Shepherd shares his experience as ME sufferer for nearly 40 years.
Article l
Thread
BBC Bedbound patient facing delay feel "buried alive"
Deborah Seymour is bedbound after a Covid infection. She has been diagnosed with Long Covid and ME but is not receiving the help she needs. She says: "I need doctors to be open minded and brave - somebody help me".
Article l
Thread
Switzerland
A French article in Swiss state news media RTS writes about people with Long COVID going bankrupt because of disability waiting times.
Article |
Thread
The Sick Times "My Mom was disabled by ME, but I didn’t understand until I developed Long COVID. I wrote an apology letter to her."
In the first essay of the new Color of Long COVID series Jacqueline E. Luciano describes how her experience with Long COVID led her to better understand her mother’s experience with ME decades earlier.
Essay |
Instagram post |
Thread
..........
Coming events
#
MEAction organise Caregiver Support Calls on Zoom on the third Saturday of each month. The next call is December 21.
More information l
Thread
..........
In memory
Judith Schoßböck (1981 - 2024)
Scientist, artist and activist Judith Schoßböck has died. Judith was the founder of the BlackFerkStudio which provided touching insights into life with ME/CFS. The Austrian patient organisation Österreichische Gesellschaft für ME/CFS has written more about her on Facebook: "With this post, we would like to express our appreciation and honor the memory of Judith's dedication, creativity and projects. With her tireless educational work for #MECFS, she will be remembered as a role model."
Post from ÖG CFS/ME l
Thread
...........
Research news
Open Medicine Foundation
OMF has initiated an ME/CFS biomarker study, called BioQuest. It plans to measure over 10,000 proteins and metabolites in blood samples of up to 1,200 patients and controls that have already been collected and stored.
Article |
Thread
CureME
The CureME team that manages the UK ME/CFS Biobank has published an overview of the research work they produced this year. This include studies in HHV-6, low-dose naltrexone, and oxidative stress.
Article |
Thread
............
Research
ME/CFS research
Frontiers in physiology
Effectiveness of a brief multicomponent intervention to improve physical activity level and functional capacity in fibromyalgia and chronic fatigue syndrome (Synchronize+) - Martin-Borras et al.
The authors conducted a randomized trial in 143 patients with fibromyalgia and/or CFS. The goal is to examine the effect of a brief multicomponent intervention based on physical activity, nutrition, and chronobiology.
Article |
Thread
BMJ Open
Serial Paediatrics Omics Tracking in Myalgic Encephalomyelitis (SPOT-ME): protocol paper for a multidisciplinary, observational study of clinical and biological markers of paediatric myalgic encephalomyelitis/chronic fatigue syndrome in Australian adolescents aged 12–19 years — Natalie Thomas et al.
"The longitudinal repeated-measures study design is optimal for studying heterogeneous chronic diseases like ME/CFS as it can detect subtle changes, control for individual differences, enhance precision and boost statistical power."
Article |
Thread
Long Covid research
JAMA Network Open
Prevalence of Post–COVID-19 Condition and Activity-Limiting Post–COVID-19 Condition Among Adults — Anjel Vahratian et al.
"In 2023, among 29 522 respondents […] 8.4% (95% CI, 8.0%-8.8%) of adults in the US reported they ever had PCC, 3.6% (95% CI, 3.3%-3.9%) currently had PCC, and 2.3% (95% CI, 2.1%-2.5%) currently had activity-limiting PCC."
Article |
Thread
Cancer Medicine
Post-acute sequelae of COVID-19 in cancer patients: Two cohorts in UK and Hong Kong — Eric Yuk Fai Wan et al.
"Cancer patients with COVID-19 consistently showed significantly higher risk of major cardiovascular diseases […] CVD death […] and all-cause mortality"
Article |
Thread
Infectious Medicine
Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions — Kamdar et al.
"The presence of histopathological evidence of increased collagen deposition, abnormal [cardiac MRI] findings, and evidence of upregulated ECM related pathways suggests that systemic and vascular inflammation are contributing factors to symptom burden in post-COVID-19 clinical syndromes."
Article |
Thread
Preprints with The Lancet
Symptoms and Pathophysiology of Post-Acute Sequelae of SARS-CoV-2 (PASC): A Cohort Study — Robineau et al.
"Inflammatory biomarkers associated with COVID-19 severity (IFNγ, IL-8, and CD163) were associated with a wide range of symptoms. Biomarkers associated with vascular damage (VCAM-1, ICAM-1) were also associated with several symptoms."
Article |
Thread
Preprint: MedRxiv
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry — Art Schuermans et al.
"our findings indicate that thromboembolic pathways may contribute to long COVID independently of acute disease severity"
Article |
Thread
Analytical and Bioanalytical Chemistry
Long-term dysregulation of plasma peptidome in mild and multiple COVID-19 recovered patients revealed by a novel efficient peptidomics workflow — Song et al.
"results revealed that in patients with mild symptoms from the first infection, abnormal regulation of lipid metabolism could persist until the third month post-recovery, while peptide changes related to coagulation dysfunction and infection would continue until the sixth month post-recovery."
Article |
Thread
Brain and Cognition
Neuroimaging markers of cognitive fatigue in individuals with post-acute sequelae of SARS-CoV-2 infection — Niemczak et al.
"Findings suggest that individuals with PASC and CF may need to exert greater mental effort during demanding cognitive tasks, reflected in recruitment of a broader network of brain regions."
Article |
Thread
Brain Communications
Vaccination prior to SARS-CoV-2 infection does not affect the neurologic manifestations of long COVID — Mukherjee et al.
"While vaccination decreases the severity of acute COVID-19 infection and the rate of hospitalization and death, the sobering conclusion of our study is that vaccination prior to infection did not alter the subsequent neurologic manifestations of long COVID in our clinic population."
Article |
Thread
Preprint: BioRxiv
Gut Microbiome Signatures During Acute Infection Predict Long COVID — Isin Y. Comba et al.
"Our results demonstrate that the gut microbiome during acute SARS-CoV-2 infection can potentially identify patients at risk of developing LC. Variations in the gut microbiome may be intricately linked to the pathophysiology of specific LC symptoms, including gastrointestinal/sensory and fatigue-only clusters."
Article |
Thread
Preprint: MedRxiv
“It’s a moving target”: Experiences of pacing to reduce symptom exacerbation among adults living with Long COVID – Results from an international community-engaged qualitative research study — Kiera McDuff et al.
"Participants experienced pacing as being a helpful living strategy to prevent or reduce symptom exacerbation. Many were knowledgeable, and had learned about pacing through online community support groups for people living with Long COVID or other energy-limiting chronic conditions. However, the experiences of pacing were described as a ‘moving target’, involving many challenges, and requiring time, effort, and trial and error to implement effectively."
Article |
Thread
Clinical Autonomic Research
Treatments for Long COVID autonomic dysfunction: a scoping review — Treadwell et al.
"Overall, we found a general disconnect between the numerous treatments recommended by ten guidelines and the 11 treatments that have been studied empirically. Given the poorly understood nature of autonomic dysfunction, as well as the novelty of Long COVID, this mismatch is understandable."
Article |
Thread
Hormone and Metabolic Research
A Single-Center Pilot Study of Therapeutic Apheresis in Patients with Severe Post-COVID Syndrome — Johannes Korth et al.
"Following apheresis, 12 out of 20 (60%) patients reported improvement in tiredness, while 6 (30%) reported no change and 2 (10%) reported worse tiredness."
Article |
Thread
ResearchSquare
Increased physical performance and reduced fatigue after personalised physiotherapy and nutritional counselling in long COVID - Jimenez-Garcia et al.
This Belgian pilot study tested a combination of symptom-contingent pacing and dietary advice for Long Covid patients. The results indicate no significant clinical effect.
Article |
Thread
............
S4ME social media:
Forum,
Facebook,
Twitter,
Mastodon,
Bluesky and
YouTube